The anticipated authorization of a third coronavirus vaccine has raised a new question for many Americans: Which shot should I get?

The benefits of being vaccinated against COVID outweigh any risk of serious side effects.

Wednesday February 24, 2021 11:00 am - 12:00 pm ET They came to public health committed to save lives. They are leaving in the wake of attacks, harassment, and even death threats. More than 180 state and local public health officials have left their jobs in less than a year, depleting and stymying our public health system just when we need it most.

A new study involving more than half a million people who were vaccinated in Israel strongly suggests the vaccines have remained effective in preventing symptoms of COVID-19.

Six months after the arrival of the first COVID-19-warning smartphone apps built on a privacy-preserving framework from Apple and Google, they remain yet another coronavirus pandemic scarcity.

Drug company officials say they are speeding up delivery of COVID-19 vaccines in the United States.

As the coronavirus vaccines continue to be distributed across the country, there have been anecdotal reports of people experiencing more side effects after the second dose, but experts say this is a "normal immune response."

CBS News lead national correspondent David Begnaud spoke with Johns Hopkins' head COVID-19 data scientist, whose team created one of the world's premier coronavirus data tracking resources.

While you should consult your doctor if you have concerns, medical experts say the vast majority of prescription drugs will work just as well after you get a COVID-19 vaccine, and they won't diminish the effectiveness of the shot you're getting to ward off the coronavirus.

More than 500,000 people have died from COVID-19 in the U.S.

Friday February 19, 2021 12:00-12:30 ET Join experts from the Johns Hopkins Coronavirus Resource Center (CRC) at 12pm ET on Fridays for timely, accessible updates on the state of the pandemic and the public health response.

Biden administration officials, pharmaceutical companies and scientists are racing to get ahead of a coronavirus that has become a more aggressive shape shifter than many expected.